Prospectus

Moleculin Biotech, Inc. Filed 2023-12-22 Acc 0001437749-23-035262

Documents 1

2025-02-26 424B5 Prospectus
2023-12-27 4 Chief Financial Officer bought 28,986 shares at $0.69 ($20,000)
2023-12-27 4 Director bought 14,493 shares at $0.69 ($10,000)
2023-12-22 424B5 Prospectus
2023-12-21 8-K Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
2023-12-18 8-K Regulation FD disclosure
2021-06-25 424B5 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading mbrx20231110_424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…